Wellington Management Group
NVET

Wellington Management Group’s Nexvet Biopharma plc Ordinary Shares NVET Stock Holding History

Wellington Management Group’s Portfolio NVET Stock Details NVET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-459,135
Closed -$1.57M – 2296
2015
Q4 		$1.57M Sell
459,135
-866,420
-65% -$3.42M ﹤0.01% 1694
2015
Q3 		$4.83M Buy
1,325,555
+7,968
+0.6% +$36.3K ﹤0.01% 1370
2015
Q2 		$6.52M Sell
1,317,587
-5,283
-0.4% -$36.6K ﹤0.01% 1330
2015
Q1 		$10.6M Buy
+1,322,870
New +$12.5M ﹤0.01% 1221

Other funds holding NVET

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
CI
Cowen Inc New York $1.39B AUM 60.14% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wellington Management Group's NVET Position: Q1 2016 in Review

Wellington Management Group sold out of Nexvet Biopharma plc Ordinary Shares (NVET) in Q1 2016, closing a stake of 459,135 shares — an estimated $1.57M sold.

Wellington Management Group first reported a position in NVET in Q1 2015 and held it in 4 quarters. The position peaked at $10.6M in Q1 2015. 18 funds tracked by Wall St. Rank hold NVET as of Q1 2016.

  • Wellington Management Group reported no remaining Nexvet Biopharma plc Ordinary Shares position as of Q1 2016 after selling out during the quarter.
  • Wellington Management Group sold 459,135 Nexvet Biopharma plc Ordinary Shares shares in Q1 2016, an estimated $1.57M.
  • Wellington Management Group first reported a position in Nexvet Biopharma plc Ordinary Shares in Q1 2015 and held it in 4 quarters.
  • Wellington Management Group's Nexvet Biopharma plc Ordinary Shares position peaked at $10.6M in Q1 2015.
  • 18 funds tracked by Wall St. Rank held Nexvet Biopharma plc Ordinary Shares as of Q1 2016.

Based on Wellington Management Group's 13F filing for Q1 2016, filed 13 May 2016.